DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Corticosteroides,
Antagonistas dos Receptores Histamínicos,
Antagonistas de Leucotrienos,
Administração Intranasal,
Administração Oral,
Fatores Etários,
Quimioterapia Combinada,
Antagonistas dos Receptores Histamínicos/uso terapêutico,
Antagonistas de Leucotrienos/uso terapêutico,
Rinite Alérgica Sazonal,
Corticosteroides/administração & dosagem,
Corticosteroides/uso terapêutico,
Rinite Alérgica Sazonal/diagnóstico,
Rinite Alérgica Sazonal/tratamento farmacológico
Jouneau, S;
Dres, M;
Guerder, A;
Bele, N;
Bellocq, A;
Bernady, A;
Berne, G;
Bourdin, A;
Brinchault, G;
Burgel, P. R;
Carlier, N;
Chabot, F;
Chavaillon, J. M;
Cittee, J;
Claessens, Y. E;
Delclaux, B;
Deslée, G;
Ferré, A;
Gacouin, A;
Girault, C;
Ghasarossian, C;
Gouilly, P;
Gut-Gobert, C;
Gonzalez-Bermejo, J;
Jebrak, G;
Le Guillou, F;
Léveiller, G;
Lorenzo, A;
Mal, H;
Molinari, N;
Morel, H;
Morel, V;
Noel, F;
Pégliasco, H;
Perotin, J. M;
Piquet, J;
Pontier, S;
Rabbat, A;
Revest, M;
Reychler, G;
Stelianides, S;
Surpas, P;
Tattevin, P;
Roche, N.
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of ...
This guideline covers diagnosing and managing bronchiolitis in children. It aims to help healthcare professionals diagnose bronchiolitis and identify if children should be cared for at home or in hospital. It describes treatments and interventions that can be used to help with the symptoms of bronchiolit...
Bressler, B;
Marshall, J. K;
Bernstein, C. N;
Bitton, A;
Jones, J;
Leontiadis, G. I;
Panaccione, R;
Steinhart, A. H;
Tse, F;
Feagan, B.
BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal septicaemia (blood poisoning) in babies, children and young people under 16. It aims to reduce deaths and disability by promoting early recognition of symptoms and timely effective management. For recommenda...
Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describ...
Bronquiolite Obliterante/diagnóstico,
Bronquiolite Obliterante/tratamento farmacológico,
Pulmão/patologia,
Azitromicina/uso terapêutico,
Ciclosporina/uso terapêutico,
Tacrolimo/uso terapêutico,
Tomografia Computadorizada por Raios X,
Biópsia,
Corticosteroides/uso terapêutico,
Volume Expiratório Forçado,
Refluxo Gastroesofágico,
Gerenciamento Clínico,
Fatores de Risco
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on glomerulonephritis (GN) is intended to assist the practitioner caring for patients with GN. Two chapters of this guideline focus specifically on nephrotic syndrome in children. Guideline development followed a thoro...
Esta guía constituye una orientación para el manejo de pacientes adultos portadores de
asma bronquial. No es su objetivo establecer estándares de cuidado para pacientes
individuales, los que sólo pueden ser determinados por profesionales competentes en
base a disponer del máximo de información clí...
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Esclerose Múltipla/terapia,
Esclerose Múltipla/diagnóstico por imagem,
Esclerose Múltipla/tratamento farmacológico,
Espectroscopia de Ressonância Magnética/métodos,
Interferon beta/uso terapêutico,
Acetato de Glatiramer/uso terapêutico,
Azatioprina/uso terapêutico,
Natalizumab/uso terapêutico,
Cloridrato de Fingolimode/uso terapêutico,
Mitoxantrona/uso terapêutico,
Metotrexato/uso terapêutico,
Ciclofosfamida/uso terapêutico,
Transplante de Células-Tronco Hematopoéticas,
Corticosteroides/uso terapêutico
Los objetivos de esta GPC son: Contribuir a la disminución de la prevalencia e incidencia de UPP en la población de la Comunidad Valenciana; Aumentar la calidad de los cuidados prestados a las personas con UPP, así como a aquellas con riesgo de desarrollarlas; Promover un estudio epidemiológico descr...
Úlcera por Pressão/epidemiologia,
Úlcera por Pressão/tratamento farmacológico,
Úlcera por Pressão/diagnóstico,
Fatores de Risco,
Espanha/epidemiologia,
Procedimentos Clínicos/organização & administração,
Manejo da Dor,
Anti-Infecciosos Locais/uso terapêutico,
Corticosteroides/uso terapêutico,
Analgesia,
Hipnóticos e Sedativos/uso terapêutico,
Antibióticos Antineoplásicos/uso terapêutico
